Sublingual Immunotherapy: Tablets and Drops

Treatment Guide

Sublingual immunotherapy places a selected allergen under the tongue on a regular schedule. FDA-approved tablets and custom liquid allergy drops are different products with different evidence, labeling, coverage, and safety instructions, so the exact option should be named clearly.

Request an appointment Find a clinic

Sublingual Immunotherapy: Tablets and Drops | Modena Health

Understanding Sublingual Immunotherapy (SLIT)

Sublingual Immunotherapy (SLIT): what the first evaluation should clarify

Tablets and allergy drops

Tablet eligibility depends on the confirmed allergen, age, season, and product labeling. Custom drops may include different allergens, but formulation, evidence, insurance coverage, and insurance coverage should be discussed directly.

First dose and home treatment

The first dose is commonly given under medical observation. Later doses are taken at home according to written instructions. Mouth itching and throat irritation can occur, while systemic reactions are less common but still possible.

Review the allergic rhinitis treatments guide for symptom patterns, evaluation questions, management options, and reasons to seek specialist care.

Modena Health physician speaking with a patient in an exam room.

Care Options

Choosing SLIT or allergy shots

The decision considers the allergen profile, asthma control, schedule, ability to take daily treatment, evidence for the product, insurance coverage, and preference. Neither route should begin from a positive test that does not match symptoms.

Questions About the Proposed SLIT Product

A consultation should identify the exact tablet or liquid formulation being considered, the relevant allergy and the evidence for that use. FDA approval applies to specific sublingual tablets, while ACAAI describes allergy drops as off-label and not FDA-approved.

Who explains supervision and follow-up?

The prescribing team explains the proposed program, individual instructions and contact arrangements. This page does not supply a home dosing schedule or restart rules.

Where can I compare the terminology?

The allergy drops and tablets article explains that distinction. The wider immunotherapy comparison covers shots alongside sublingual options, without choosing one for the reader.

Know the Next Step

Daily treatment requires a long-term plan

SLIT is taken consistently at home over an extended period. Discuss expected time to benefit, treatment duration, missed doses, travel, storage, follow-up, and the symptoms that require holding a dose and contacting the team.

When comparing SLIT with allergy shots, consider allergen coverage, evidence, convenience, insurance requirements, clinic visits, adherence, and individual risk—not simply a preference to avoid needles.

Care Connected with Sublingual Immunotherapy (SLIT)

Evaluation and treatment related to Sublingual Immunotherapy (SLIT)

These diagnostic and treatment topics can shape a focused sublingual immunotherapy (slit) discussion.

Allergy Immunotherapy

Allergy Immunotherapy can clarify a separate question that often appears while evaluating Sublingual Immunotherapy (SLIT).

View guide

Allergy Shots (Subcutaneous Immunotherapy)

Use the Allergy Shots (Subcutaneous Immunotherapy) guide to compare preparation, evidence, and next steps alongside Sublingual Immunotherapy (SLIT).

View guide

Sublingual Immunotherapy: Allergy Drops and Tablets

Open Sublingual Immunotherapy: Allergy Drops and Tablets for connected testing or treatment decisions that may follow a Sublingual Immunotherapy (SLIT) discussion.

Read guide

Patient guide

Sublingual Immunotherapy: decisions, preparation, and safety

Quick answer

Sublingual immunotherapy, or SLIT, is a form of allergen immunotherapy given under the tongue. In the United States, FDA-approved tablets are available for certain grass pollens, ragweed pollen, and house dust mite allergy; custom liquid allergy drops are prescribed off-label and are not FDA-approved as allergy-drop products.

Who may want to ask about it

SLIT may be discussed when allergic rhinitis or related symptoms match a clinically relevant allergen and a patient wants a disease-modifying option. The decision also considers asthma control, age and product labeling, other health conditions, adherence, and the ability to follow home safety instructions.

What the visit or test may answer

The clinician connects symptoms and exposure timing with focused allergy testing, then reviews the exact product, its allergen, expected season or duration, first-dose procedure, daily routine, missed-dose rules, and response measures.

How to prepare

Bring prior skin or blood test results, a symptom calendar, medication and inhaler lists, asthma history, swallowing or esophageal symptoms, dental procedures, pregnancy plans, travel needs, and insurance information. Ask the office before changing antihistamines or asthma treatment.

Limits and safety

SLIT treats only the allergen or allergens included in the prescribed product. It does not provide immediate relief, does not treat an active reaction, and should not be assumed to cover every positive allergy test.

When symptoms need urgent care

Severe throat tightness, breathing difficulty, fainting, rapidly spreading symptoms, or suspected anaphylaxis requires the prescribed emergency plan and immediate care. New persistent swallowing difficulty, food sticking, or chest discomfort should be reported promptly because eosinophilic esophagitis is a relevant safety concern.

Alternatives to discuss

Alternatives may include optimized symptom treatment, exposure reduction, allergy shots, or choosing not to begin immunotherapy. The best comparison accounts for allergen coverage, evidence, clinic access, daily adherence, cost, and safety.

A useful next step

Ask for the exact product name, FDA status, allergen coverage, first-dose plan, home-dose instructions, epinephrine plan, interruption rules, expected duration, and total cost before deciding.

Name the Product

FDA-approved SLIT tablets and custom allergy drops are not the same

The FDA lists allergen-extract tablets for specific grass, ragweed, and house dust mite allergies. Each tablet has its own age range, timing, contraindications, dosing instructions, and prescribing information. The evidence for one tablet cannot automatically be applied to a different allergen or formulation.

Some allergy practices prescribe custom liquid extracts under the tongue. These liquid mixtures are commonly called allergy drops, but the mixtures are not FDA-approved as sublingual allergy products in the United States. That affects standardization, evidence, dosing, insurance coverage, and informed consent. A transparent consultation should identify whether the discussion concerns a named approved tablet or an off-label liquid formulation.

Confirm Clinical Relevance

A positive allergy test alone does not select SLIT

Testing shows sensitization, while treatment should target an allergen that actually fits the symptom pattern. Dust-mite treatment makes sense when exposure and perennial symptoms support that relationship. Seasonal tablet timing should match the relevant pollen and the product instructions. Broad treatment of every positive result can add cost and burden without addressing the main problem.

The clinician also reviews whether symptoms are controlled with current measures, how much they affect sleep, school, work, and outdoor activity, and whether the patient prefers immunotherapy after understanding alternatives. Asthma must be assessed because uncontrolled or severe asthma can increase treatment risk and may make SLIT inappropriate until the breathing plan is stable.

Start Safely

The first dose, observation, and home emergency plan

For FDA-approved tablets, the first dose is given under medical supervision with observation according to the product labeling. The prescriber reviews how to place the tablet, how long to keep it under the tongue, what to avoid immediately afterward, and how to recognize local versus systemic reactions. Later doses are generally taken at home on a consistent schedule.

Patients prescribed a tablet are typically also prescribed epinephrine and taught when and how to use it. A written plan should state what symptoms require epinephrine and emergency care, what symptoms justify calling before the next dose, and how to handle a missed or interrupted course. General internet instructions should never replace the exact product plan.

Plan for Daily Use

Oral symptoms, missed doses, illness, dental work, and travel

Itching or tingling in the mouth, lip or tongue discomfort, throat irritation, and ear itching can occur, especially early in treatment. The clinical team explains which expected reactions can be observed and which symptoms signal a more serious response. Persistent swallowing difficulty, pain with swallowing, food sticking, or chest discomfort deserves prompt review.

Oral sores, dental procedures, tooth loss, fever, asthma worsening, travel across time zones, and a prolonged dosing gap may change the plan. Instructions differ by product and duration of interruption. Before travel, patients should confirm storage, refills, dose timing, epinephrine access, and how to reach the clinic. Consistent daily use matters because SLIT is a long-term program rather than an occasional symptom medicine.

Measure the Right Outcome

When benefit may appear and how long treatment may continue

The goal is usually fewer symptoms and less medication need during relevant exposure, with better sleep, activity, or daily function. Benefit is not judged by how the mouth feels after a dose or by repeating allergy tests alone. A symptom and medication record can make follow-up more objective.

Seasonal and year-round products have different initiation schedules, and immunotherapy benefit develops gradually. For patients who benefit from inhalant allergen immunotherapy, current guidance supports a minimum course of about three years, while the total duration is individualized. Ask when the first response review will occur and what would lead to continuing, adjusting, or stopping.

Compare the Options

SLIT tablets, custom drops, and allergy shots compared

These pathways differ in regulatory status, allergen coverage, routine, evidence, and cost.

SLIT tablets, custom drops, and allergy shots compared
Option	How it is used	Key decision points
FDA-approved SLIT tablet	First dose under supervision, then regular home dosing for the named allergen	Product indication, age range, asthma status, epinephrine, schedule, and labeled contraindications
Custom liquid allergy drops	Off-label liquid mixture used under the tongue according to a clinic protocol	Not FDA-approved as allergy drops; formulation, evidence, dosing, consent, and coverage require explicit discussion
Allergy shots (SCIT)	Clinic injections through build-up and maintenance with post-dose observation	Broader selected allergen coverage, visit frequency, injection reactions, asthma control, and transportation
Symptom treatment only	Medicines and exposure steps matched to symptoms	May control symptoms without the long duration and adherence burden of immunotherapy

Patient questions

Frequently asked questions about Sublingual Immunotherapy

What is sublingual immunotherapy?

SLIT delivers selected allergen treatment under the tongue. It includes FDA-approved tablets for specific allergens and separately prescribed off-label liquid allergy drops.

Which allergy tablets are FDA-approved in the United States?

The FDA lists tablets for certain grass pollens, ragweed pollen, and house dust mite allergy. The clinician should name the exact product and confirm its current labeling and age range.

Are liquid allergy drops FDA-approved?

Custom liquid allergen extracts used as drops are not FDA-approved as sublingual allergy-drop products in the United States. Ask about the evidence, formulation, dosing, cost, and off-label consent.

Is SLIT safer than allergy shots?

The routes have different reaction patterns and responsibilities. Serious reactions are uncommon but possible with either. Individual risk, asthma control, product labeling, and adherence should guide the comparison.

Why is the first tablet dose given in the clinic?

Supervised first dosing allows observation for a reaction and gives the patient a chance to learn the exact administration and emergency plan before home use.

Do I need epinephrine while taking an allergy tablet?

FDA-approved tablet plans generally include prescribed epinephrine and training. Follow the exact product and prescriber instructions rather than assuming local mouth symptoms are always harmless.

Can SLIT treat all of my allergies at once?

No. Approved tablets treat named allergens, and any custom formulation has defined contents. Treatment should focus on allergens that match symptoms and exposure.

What happens if I miss several doses?

Restart instructions depend on the product and length of the gap. Contact the prescribing clinic before resuming after a significant interruption rather than doubling a dose.

Can I take SLIT if I have asthma?

Some patients with asthma can use SLIT, but severe or uncontrolled asthma is a major safety concern. The clinician must assess control and product-specific contraindications.

How long does sublingual immunotherapy take?

Benefit develops over time, and a multi-year course is common for patients who respond. The starting season and total duration depend on the allergen, product, response, and shared plan.

Plan the next sublingual immunotherapy (slit) conversation

Bring the symptom, reaction, testing, and treatment records named in this Sublingual Immunotherapy (SLIT) guide so the visit can answer a focused question.

Request an appointment Find a clinic

Appointments & Insurance

Scheduling made easy for your experience.

We work with many major insurance carriers.

Don’t see your carrier?

Insurance participation varies by plan, provider, network, and location. Please contact our team with your insurance card to confirm current participation. View participating plans.